KCNAB1

KCNAB1 encodes the cytoplasmic Kvβ1 auxiliary subunit of voltage-gated Kv1 potassium channels, which associates with pore-forming Kv1α subunits at the membrane and converts otherwise non-inactivating channels into rapidly (A-type) inactivating ones via its N-terminal inactivating domain (PMID:8938711). Multiple splice variants (Kvβ1.1, Kvβ1.2, Kvβ1.3) arise from alternative 5′ exon use and differ in inactivation potency through differences in their N-terminal domains, which compete with the Kv1.4α inactivating domain for a shared receptor site on Kv1α (PMID:8938711). High-affinity binding to Kv1.5 drives Kvβ1.3 from a cytoplasmic to a membrane localization and confers pronounced inactivation; this inactivating function is gated by the redox state of bound pyridine nucleotide, as oxidized NAD⁺ abolishes Kvβ1.3-induced inactivation while NADPH permits it, providing a mechanism linking cellular metabolic state to K⁺ channel activity (PMID:12604247). In coronary arterial myocytes Kvβ1 forms protein–protein complexes with both Kv1.5 and Kvβ2, though Kvβ2 rather than Kvβ1 is the principal chaperone for Kv1.5 sarcolemmal trafficking (PMID:28342889). Beyond channel modulation, Kvβ1.1 has a sex-specific cardiac role: its loss in female mice produces cardiac hypertrophy, action-potential prolongation, and elevated myosin heavy chain α (MHCα) expression, in part through a direct Kvβ1.1–MHCα interaction, whereas male knockouts show electrical (QTc/APD) prolongation without hypertrophy (PMID:27038296). In the cerebral cortex, Kcnab1 variant 1.1 marks a molecularly defined subpopulation of subplate/layer-6b neurons in primary somatosensory cortex that project unilaterally to primary motor cortex (PMID:31130851).

1. 1996 High

   Established that KCNAB1 is not a channel itself but an auxiliary subunit that imparts rapid A-type inactivation onto non-inactivating Kv1α channels, defining its core molecular function.

   Evidence Heterologous coexpression of hKvβ1.1/1.2 with hKv1.5 in 293 cells, patch-clamp, and inactivating-domain competition assay

   PMID:8938711

   Open questions at the time

   • Inactivation potency differences among splice variants not resolved structurally
   • Receptor site on Kv1α not mapped at residue level
2. 1996 High

   Localized the human Kvβ1 gene to chromosome 3q26.1, providing the genomic anchor for the locus.

   Evidence Somatic cell hybrid mapping, FISH, and YAC library PCR screening

   PMID:8838324

   Open questions at the time

   • Mapping alone gives no functional or regulatory information
3. 1998 Medium

   Characterized KCNAB1 gene architecture (≥350 kb, 14 ORF exons) and showed splice variants arise from alternative 5′ exon use, while related Kvβ3.1 also confers A-type current on Kv1.5.

   Evidence Gene structure analysis plus heterologous coexpression of Kvβ3.1 with Kv1.5 in CHO cells and patch-clamp

   PMID:9857044

   Open questions at the time

   • Functional electrophysiology in this study focused on Kvβ3.1 (KCNA3B), not KCNAB1 product directly
   • Regulation of alternative 5′ exon usage unknown
4. 2003 Medium

   Demonstrated that Kvβ1–Kv1.5 binding drives membrane localization and that pyridine-nucleotide redox state controls whether Kvβ1 imparts inactivation, linking the AKR-domain cofactor occupancy to channel behavior.

   Evidence COS-7 transient transfection, immunofluorescence localization, and patch-clamp with intracellular NAD⁺ vs NADPH dialysis

   PMID:12604247

   Open questions at the time

   • Single lab, single paper
   • Physiological redox concentrations and in vivo relevance not established
   • Catalytic mechanism of the AKR domain not directly assayed
5. 2016 High

   Revealed a sex-specific cardiac role beyond channel modulation, with Kvβ1.1 loss causing female-specific hypertrophy via MHCα upregulation and a direct Kvβ1.1–MHCα interaction.

   Evidence KCNAB1 knockout mice (both sexes), ECG/monophasic action potential, echocardiography, siRNA knockdown in H9C2, Western blot, and protein binding assay

   PMID:27038296

   Open questions at the time

   • Molecular basis of sex-specificity unknown
   • How Kvβ1–MHCα binding regulates MHCα expression not defined
6. 2017 Medium

   Placed Kvβ1 within a multi-subunit complex with Kv1.5 and Kvβ2 in arterial myocytes and showed Kvβ2, not Kvβ1, is the dominant trafficking chaperone for Kv1.5.

   Evidence In situ proximity ligation assay, confocal microscopy, membrane fractionation, and Kvβ2-null mouse

   PMID:28342889

   Open questions at the time

   • Distinct functional contribution of Kvβ1 vs Kvβ2 to current properties not isolated
   • Stoichiometry of the Kv1.5/Kvβ1/Kvβ2 assembly unclear
7. 2019 Medium

   Identified Kcnab1 variant 1.1 as a marker of a discrete unilaterally projecting subplate/layer-6b cortical neuron population, extending its biology to neuronal circuit identity.

   Evidence Retrograde tracing, in situ hybridization, microarray, and immunofluorescence co-labeling with L6b/SP markers in mouse cortex

   PMID:31130851

   Open questions at the time

   • Functional role of Kvβ1 in these neurons not tested
   • Whether channel-modulating activity underlies the marker phenotype unknown

• It remains unknown how the redox-sensing AKR domain, the cardiac MHCα interaction, and the cortical neuronal identity functions are mechanistically integrated, and no human disease linkage is established in this corpus.
• No structural model of the Kvβ1–Kv1α complex in the corpus
• No human phenotype/disease variant described
• Physiological enzymatic substrate of the AKR domain unidentified